Peptides containing N-substituted L-amino acids for...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S008100, C530S350000, C530S402000, C530S300000

Reexamination Certificate

active

07125838

ABSTRACT:
Peptide is disclosed which is capable of binding to β-strand in a separate peptide-containing molecule to form β-sheet, wherein said peptide is selectively Nα-substituted in one edge (first) of the β-strand-forming section of said peptide while the other edge (second) in the opposite orientation to the first edge in view of peptide backbone plane remains Nα-unsubstituted. Such the Nα-substituted peptide is capable of preventing association of said peptide with other β-strand (target) but permits interaction of said peptide with target β-strand in separate peptide-containing molecules through the Nα-unsubstituted edge.

REFERENCES:
patent: 6034211 (2000-03-01), Kelly
patent: 0885904 (1998-12-01), None
patent: WO 96/28471 (1996-09-01), None
patent: WO 97/21728 (1997-06-01), None
patent: WO 97/46547 (1997-12-01), None
Quibell, M. et al. (1995) Improved preparation of beta-amyloid(1-43): structure insight leading to optimal positioning of N-(2-hybroxy-4-methyoxybenzyl) (Hmb) backbone amide protection. J. Chem. Soc. PERKIN Trans. vol. 1, pp. 2019-2024.
Miller, S. M. et al. (1995) comparison of the proteolytic susceptibilities of homologous L-amino acid, D-amino acid, and N-substituted glycine peptide and peptoid oligomer, Drug Dev. Res. vol. 35, pp. 20-32.
Jakubowski, H., “Biochemistry, Chapter 2 G”—“Protein structure”, accessed on Internet at http://employees.csbsju.edu/hjakubowski/classes/ch331/protstructure/olprosectertpred.html on Feb. 18, 2005.
Penchit Chitnumsub et al., “The Nucleation of Monomeric Parallel β-Sheet-Like Structures and their Self-Assembly in Aqueous Solution”, (1999), Bioorganic & Medicinal Chemistry, vol. 7, pp. 39-59.
Andrew J. Doig, “A Three Stranded β-Sheet Peptide in Aqueous Solution Containing N-Methyl Amino Acids to Prevent Aggregation”, (1997), XP-002152179, Chem. Commun., pp. 2153-2154.
Mark A. Findeis et al., “Modified-Peptide Inhibitors of Amyloid β-Peptide Polymerization”, (1999), Biochemistry, vol. 38, pp. 6791-6800.
Kerstin Mohle et al., “Secondary Structure Formation in N-Substituted Peptides”, (1998), J. Peptide Res., vol. 51, pp. 19-28.
Monica M. Pallitto et al., “Recognition Sequence Design for Peptidyl Modulators of β-Amyloid Aggregation and Toxicity”, (1999), American Chemical Society, vol. 38, pp. 3570-3578.
Eric Vives et al., “A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates Through the Plasma Membrane and Accumulates in the Cell Nucleus”, (1997), The Journal of Biological Chemistry, vol. 272, No. 25, pp. 16010-16017.
Hilbich et al, J. Mol. Biol., vol. 228, pp. 460-473, 1992, Substitutions of Hydrophobic Amino Acids Reduce the . . . .
Wood et al, Biochemistry, vol. 34, pp. 724-730, 1995, Prolines and Amyloidogenicity in Fragments of the Alzheimer's Peptide . . . .
Innouye et al, Biophysical Journal, vol. 64, pp. 502-519, Feb. 1993, Structure of β-crystallite assemblies formed by Alzheimer . . . .
Neurobiology of Aging, vol. 11, 1990, Abstracts of Second International Conference on Alzheimer's Disease, p. 302.
Clements et al, Neuroscience Ltrs., vol. 161, 1993, pp. 17-20, Effects of the mutation Glu22to Gln and Ala21to Gly on the . . . .
Jayawickrama et al, Journal of Biomolecular . . . , vol. 13, No. 2, 1995, pp. 229-244, Conformational Analysis of the . . . .
Brack et al, Origins of Life & Evolution . . . , vol. 20, 1990, pp. 139-144, Chemical Activity of Simple Basic Peptides.
Wen et al, Journal of Biol Chem, vol. 268, No. 22, Aug. 5, 1993, pp. 16401-16405, Structure-Function Relationships in an . . . .
Kirschner et al, Proc Natl Acad Sci, vol. 84, Oct. 1987, pp. 6953-6957, Synthetic peptide homologous to β protein from . . . .
Orlando et al, Biochem & Biophys Research Comm, vol. 184, No. 2, Apr. 30, 1992, Covalent Modification of Alzheimer's Amyloid . . . .
Schwarzman et al, Proc Natl Acad Sci, vol. 91, Aug. 1994, pp. 8368-8372, Transthyretin sequesters amyloid β protein and prevents . . . .
Guichard et al, Proc Natl Acad Sci, vol. 91, Oct. 1994, pp. 9765-9769, Antigenic mimicry ofnational L-peptides with retro- . . . .
Evans et al, Proc Natl Acad Sci, vol. 92, Jan. 1995, pp. 763-767, Apoliprotein E is a kinetic but not a thermodynamic inhibitor . . . .
Perutz, TIBS 24, Feb. 1999, pp. 58-63, Glutamine repeats and neurodegenerative diseases: molecular aspects.
Smith et al, Science, vol. 270, Nov. 10, 1995, pp. 980-982, Guidelines for Protein Design: The Energetics of β Sheet Side . . . .
De Alba et al, Protein Science 8, 1999, pp. 854-865, De novo design of a monomeric three-stranded antiparallel β-sheet.
Minor, Jr. et al, Nature, vol. 371, Sep. 15, 1994, pp. 264-267 Context is a major determinant of β-sheet propensity.
Soto et al, Biochemical and Biophysical Research Comm 226, 1996, pp. 672-680, Inhibition of Alzheimer's amyloidosis by . . . .
Minor, Jr. et al, Nature, vol. 380, Apr. 25, 1996, pp. 730-734 Context-dependent secondary structure formation of a designed . . . .
Tjernberg et al, Jour of Biological Chem, vol. 271, No. 15, Apr. 12, 1996, Arrest of β-Amyloid Fibril Formation by a . . . .
Ghanta et al, Jour of Biological Chem, vol. 271, No. 47, Nov. 22, 1996, A Strategy for Designing Inhibitors of β-Amyloid . . . .
Derossi et al, Jour of Biological Chem, vol. 271, No. 30, Jul. 26, 1996, Cell Internalization of the Third Helix of the . . . .
Trojanowski et al, Arch Neurol, vol. 55, Feb. 1998, pp. 151-152 Aggregation of Neurofilament and α-Synuclein Proteins in . . . .
Burgevin et al, Neuroreport 5, 1994, pp. 2429-2432, Congo-Red Protects Against Toxicity of Beta-Amyloid Peptides on Rat . . . .
Carpino et al, Jour of Chem Soc-Chem Commun, 1994, pp. 201-203, Advantageous Applications of Azabenzotriazole . . . .
Soto et al, Nature Medicine, vol. 4, No. 7, Jul. 1998, pp. 822-826, β-sheet breaker peptides inhibit fibrillogenesis . . . .
Wilmot et al, J Mol Biology, 203, 1988, pp. 221-232, Analysis and Prediction of the Different Types of β-Turn in Proteins.
Wood et al, Jour of Biological Chem, vol. 271, No. 8, Feb. 23, 1996, pp. 4086-4092, Selective Inhibition of A β Fibril . . . .
Joachim et al, Alzheimer Disease & Assoc Disorders, vol. 6, No. 1, 1992, pp. 7-34, The Seminal Role of β-Amyloid in the . . . .
Babe et al, Protein Science 1, 1992, pp. 1244-1253, Synthetic interface peptides alter dimeric assembly of the HIV 1 and 2 . . . .
Fields et al, Int J Peptide Protein Res 35, 1990, pp. 161-214, Solid phase synthesis utilizing 9-fluorenylmethoxycarbonyl . . . .
Benson et al, Int J Exp Clin Invest 3, 1996, pp. 44-56, Transthyretin amyloidosis.
Hanan et al, Int J Exp Clin Invest 3, 1996, p. 130-133, Inhibitory effect of monoclonal antibodies of Alzheimer's . . . .
Hutchinson et al. Protein Science 7, 1998, pp. 2287-2300, Determinants of strand register in antiparallel β-sheets of . . . .
Miyata et al, J Am Soc Nephrol 9, 1998, pp. 1723-1735, β-2 Microglobulin in Renal Disease.
Zutshi et al, Chemical Biology 2, 1998, pp. 62-66, Inhibiting the assembly of protein-protein interfaces.
Pollack et al, Neuroscience Ltrs 197, 1995, pp. 211-214, Sulfonated dyes attenuate the toxic effects of β-amyloid in . . . .
Price et al, Proc Natl Acad Sci, vol. 90, Jul. 1993, pp. 6381-6384, Alzheimer disease and the prion disorders amyloid . . . .
Schramm et al, Antiviral Research 30, 1996, pp. 155-170, The inhibition of human immunodeficiency virus proteases by . . . .
Merlini et al, Proc Natl Acad Sci, vol. 92, Mar. 1995, pp. 2959-2963, Interaction of the anthracycline . . . .
Hughes et al, Proc Natl Acad Sci, vol. 95, Mar. 1998, pp. 3275-3280, α2-macroglobulin associates with β-amyloid . . . .
Pappolla et al, Jour of Biol Chem, vol. 273, No. 13, Mar. 27, 1998, pp. 7185-7188, Inhibition of Alzheimer . . . .
Koepf et al, Protein Science 8, 1999, pp. 841-853, WW: An isolated three-stranded antiparallel β-sheet doma

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Peptides containing N-substituted L-amino acids for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides containing N-substituted L-amino acids for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides containing N-substituted L-amino acids for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3636059

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.